NCT07502287 2026-03-30
DUAL-NK-NB
Beijing Biotech
Phase 1/2 Recruiting
Clinical Trials
5 trialsNCT01804634 2026-03-13
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Recruiting
NCT02747407 2021-10-29
Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors
Wake Forest University Health Sciences
Completed
NCT01941758 2018-07-05
High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors
Wake Forest University Health Sciences
Phase 1 Completed
NCT01474174 2018-07-03
Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors
Wake Forest University Health Sciences
Completed